ENTG Stock Overview
Processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Entourage Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.015 |
| 52 Week High | CA$0.03 |
| 52 Week Low | CA$0.01 |
| Beta | 1.12 |
| 11 Month Change | 0% |
| 3 Month Change | 50.00% |
| 1 Year Change | 0% |
| 33 Year Change | -93.62% |
| 5 Year Change | -99.06% |
| Change since IPO | -98.24% |
Recent News & Updates
Investors Still Aren't Entirely Convinced By Entourage Health Corp.'s (CVE:ENTG) Revenues Despite 50% Price Jump
Jul 18
Entourage Health Corp.'s (CVE:ENTG) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 05Market Might Still Lack Some Conviction On Entourage Health Corp. (CVE:ENTG) Even After 50% Share Price Boost
May 31Recent updates
Investors Still Aren't Entirely Convinced By Entourage Health Corp.'s (CVE:ENTG) Revenues Despite 50% Price Jump
Jul 18Entourage Health Corp.'s (CVE:ENTG) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 05Market Might Still Lack Some Conviction On Entourage Health Corp. (CVE:ENTG) Even After 50% Share Price Boost
May 31Entourage Health Corp.'s (CVE:ENTG) Shares Leap 50% Yet They're Still Not Telling The Full Story
Apr 02Entourage Health Corp. (CVE:ENTG) Soars 50% But It's A Story Of Risk Vs Reward
Feb 08Not Many Are Piling Into Entourage Health Corp. (CVE:ENTG) Just Yet
Apr 19WeedMD Inc. (CVE:WMD) On The Verge Of Breaking Even
Jan 01
Shareholder Returns
| ENTG | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 50.0% | -6.0% | 0.9% |
| 1Y | 0% | 37.6% | 15.8% |
Return vs Industry: ENTG underperformed the Canadian Pharmaceuticals industry which returned 37.6% over the past year.
Return vs Market: ENTG underperformed the Canadian Market which returned 15.8% over the past year.
Price Volatility
| ENTG volatility | |
|---|---|
| ENTG Average Weekly Movement | 58.7% |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in CA Market | 16.6% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: ENTG's share price has been volatile over the past 3 months.
Volatility Over Time: ENTG's weekly volatility (59%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | George Scorsis | entouragehealthcorp.com |
Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.
Entourage Health Corp. Fundamentals Summary
| ENTG fundamental statistics | |
|---|---|
| Market cap | CA$4.63m |
| Earnings (TTM) | -CA$42.94m |
| Revenue (TTM) | CA$41.58m |
0.1x
P/S Ratio-0.1x
P/E RatioIs ENTG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENTG income statement (TTM) | |
|---|---|
| Revenue | CA$41.58m |
| Cost of Revenue | CA$35.92m |
| Gross Profit | CA$5.66m |
| Other Expenses | CA$48.61m |
| Earnings | -CA$42.94m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 26, 2024
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 13.62% |
| Net Profit Margin | -103.28% |
| Debt/Equity Ratio | -109.0% |
How did ENTG perform over the long term?
See historical performance and comparison